Kvika banki hf.
A shareholders’ meeting of Kvika banki hf., Reg. No. 540502-2930, will be held on Tuesday, 30 March 2021, at 4:00 pm at Hilton Reykjavík Nordica, Suðurlandsbraut 2, 108 Reykjavík.
The Agenda for the meeting is as follows:
- Motion of the Board of Directors for the merger of Kvika banki hf., TM hf. and Lykill fjármögnun hf.
- Motion of the Board of Directors to amend the company's Articles of Association in connection with the merger, i.e. concerning an increase in share capital.
- Discussion and other business legally presented.
The meeting will be held in Icelandic. Meeting documents are available on the company's website in both Icelandic and English, with the exception of the company's annual financial statements, which are only available in English. Meeting documents are available on the website https://www.kvika.is/en/investor-relations/shareholders-meeting, see also in Icelandic here: https://www.kvika.is/fjarfestaupplysingar/hluthafafundir/ and at the company's office at Katrínartún 2, 105 Reykjavík.
For further information, please find attached Announcement of Shareholders’ Meeting.
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
ITHAX Acquisition Corp III15.12.2025 22:01:00 CET | Press release
ITHAX Acquisition Corp III Announces Closing of $230 Million Initial Public Offering
Theon International PLC15.12.2025 20:59:47 CET | Press release
THEON Announces Results of the Rights Issue
Digitalist Group Oyj15.12.2025 19:08:39 CET | Press release
Digitalist Group Oyj - Managers' Transactions
Solvay S.A.15.12.2025 17:45:00 CET | Press release
Participation notification by UBS Group AG
Ipsen Pharma15.12.2025 17:30:00 CET | Press release
Ipsen completes acquisition of ImCheck Therapeutics, expanding oncology pipeline
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
